Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Malignant Melanoma

  Free Subscription


15.06.2020

6 Ann Surg Oncol
2 Br J Dermatol
1 Cancer Res
1 Eur J Dermatol
3 J Am Acad Dermatol
2 J Clin Oncol
1 Lancet Infect Dis
2 Melanoma Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. LEE AY, Friedman EB, Sun J, Potdar A, et al
    The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma.
    Ann Surg Oncol. 2020 Jun 11. pii: 10.1245/s10434-020-08708.
    PubMed         Abstract available

  2. HU Y, Brady MS
    ASO Author Reflections: Role of Sentinel Lymph Node Biopsy in T1b Melanoma.
    Ann Surg Oncol. 2020 Jun 11. pii: 10.1245/s10434-020-08564.
    PubMed        

  3. HAN D, Han G, Duque MT, Morrison S, et al
    Sentinel Lymph Node Biopsy Is Prognostic in Thickest Melanoma Cases and Should Be Performed for Thick Melanomas.
    Ann Surg Oncol. 2020 Jun 10. pii: 10.1245/s10434-020-08706.
    PubMed         Abstract available

  4. KARAKOUSIS GC, Faries MB
    Sentinel Lymph Node Biopsy for Melanoma: Buggy Whip or Roller Bearing?
    Ann Surg Oncol. 2020 Jun 9. pii: 10.1245/s10434-020-08567.
    PubMed        

  5. HU Y, Briggs A, Gennarelli RL, Bartlett EK, et al
    Sentinel Lymph Node Biopsy for T1b Melanoma: Balancing Prognostic Value and Cost.
    Ann Surg Oncol. 2020 Jun 8. pii: 10.1245/s10434-020-08558.
    PubMed         Abstract available

  6. MONCRIEFF MD, Sharma RA, Gathura E, Heaton MJ, et al
    Improved Perioperative Seroma and Complication Rates Following the Application of a 2-Layer Negative Pressure Wound Therapy System After Inguinal Lymphadenectomy for Metastatic Cutaneous Melanoma.
    Ann Surg Oncol. 2020 Jun 5. pii: 10.1245/s10434-020-08513.
    PubMed         Abstract available


    Br J Dermatol

  7. OLSEN CM
    Global trends in melanoma mortality differ by sex and age.
    Br J Dermatol. 2020 Jun 8. doi: 10.1111/bjd.19166.
    PubMed        

  8. MANRIQUE-SILVA E, Rachakonda S, Millan-Esteban D, Garcia-Casado Z, et al
    Clinical, environmental, and histological distribution of BRAF, NRAS and TERT promoter mutations among cutaneous melanoma patients. A retrospective study of 563 patients.
    Br J Dermatol. 2020 Jun 7. doi: 10.1111/bjd.19297.
    PubMed         Abstract available


    Cancer Res

  9. VANDAMME N, Denecker G, Bruneel K, Blancke G, et al
    The EMT transcription factor ZEB2 promotes proliferation of primary and metastatic melanoma while suppressing an invasive, mesenchymal-like phenotype.
    Cancer Res. 2020 Jun 5. pii: 0008-5472.CAN-19-2373.
    PubMed         Abstract available


    Eur J Dermatol

  10. EL KHOURY R, Michael-Jubeli R, Bakar J, Dakroub H, et al
    Origanum essential oils reduce the level of melanin in B16-F1 melanocytes.
    Eur J Dermatol. 2019;29:596-602.
    PubMed         Abstract available


    J Am Acad Dermatol

  11. GREENHAW BN, Covington KR, Kurley Phd SJ, Yeniay Y, et al
    Reply to Problematic methodology in a systematic review and meta-analysis of DecisionDx- Melanoma.
    J Am Acad Dermatol. 2020 Jun 8. pii: S0190-9622(20)31069.
    PubMed        

  12. MARCHETTI MA, Dusza SW, Bartlett EK
    Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma(R).
    J Am Acad Dermatol. 2020 Jun 8. pii: S0190-9622(20)31068.
    PubMed        

  13. LIU R, Ferris LK
    Reply to Comment on "Re-Evaluating the ABCD Criteria Using a Consecutive Series of Melanomas".
    J Am Acad Dermatol. 2020 Jun 2. pii: S0190-9622(20)30971.
    PubMed        


    J Clin Oncol

  14. GARBE C, Keim U, Suciu S, Amaral T, et al
    Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts.
    J Clin Oncol. 2020 Jun 12:JCO1903034. doi: 10.1200/JCO.19.03034.
    PubMed         Abstract available

  15. LO SN, Ma J, Scolyer RA, Haydu LE, et al
    Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram.
    J Clin Oncol. 2020 Jun 12:JCO1902362. doi: 10.1200/JCO.19.02362.
    PubMed         Abstract available


    Lancet Infect Dis

  16. LAU CY, Kassaye SG
    Listeria endophthalmitis in a patient receiving immunomodulatory therapy.
    Lancet Infect Dis. 2019;19:913.
    PubMed        


    Melanoma Res

  17. LUCARINI G, Simonetti O, Lazzarini R, Giantomassi F, et al
    Vascular endothelial growth factor/semaphorin-3A ratio and SEMA3A expression in cutaneous malignant melanoma.
    Melanoma Res. 2020 Jun 8. doi: 10.1097/CMR.0000000000000674.
    PubMed         Abstract available

  18. FRANKE V, Smeets PMG, van der Wal JE, van Akkooi ACJ, et al
    Complete response to talimogene laherparepvec in a primary acral lentiginous melanoma.
    Melanoma Res. 2020 Jun 8. doi: 10.1097/CMR.0000000000000673.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: